Email this article 
HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION OF PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
- Authors: Shaplygin L.V.1, Solovov V.A.1, Vozdvizhenskiy M.O.1, Matyash Y.S.1, Khametov R.Z.1, Fesenko D.V.1
-
Affiliations:
- Regional Clinical Oncology Dispensary, Samara
- Issue: Vol 10, No 2 (2014)
- Pages: 58-61
- Section: PROSTATE CANCER
- Published: 30.06.2014
- URL: https://oncourology.abvpress.ru/oncur/article/view/61
- DOI: https://doi.org/10.17650/1726-9776-2014-10-2-58-61
- ID: 61
Cite item
Full Text
Abstract
In this study the results of retrospective analysis of treatment of 311 patients in Samara Oncology Center in 2008–2011 with locally advanced prostate cancer are presented. According to the received treatment patients were divided into 3 groups: 103 underwent HIFU, 101 patients had a course of EBRT, 107 patients received only hormone therapy (HT). Overall survival in patients with locally advanced prostate cancer after HIFU therapy was 86.2 %, after EBRT and HT – 66.3% and 18.1 %, respectively. These data indicate a high clinical efficacy of ultrasound ablation.
About the authors
L. V. Shaplygin
Regional Clinical Oncology Dispensary, Samara
Email: samarasdc@yahoo.com
Russian Federation
V. A. Solovov
Regional Clinical Oncology Dispensary, Samara
Author for correspondence.
Email: samarasdc@yahoo.com
Russian Federation
M. O. Vozdvizhenskiy
Regional Clinical Oncology Dispensary, Samara
Email: samarasdc@yahoo.com
Russian Federation
Yа. S. Matyash
Regional Clinical Oncology Dispensary, Samara
Email: samarasdc@yahoo.com
Russian Federation
R. Z. Khametov
Regional Clinical Oncology Dispensary, Samara
Email: samarasdc@yahoo.com
Russian Federation
D. V. Fesenko
Regional Clinical Oncology Dispensary, Samara
Email: samarasdc@yahoo.com
Russian Federation
References
Supplementary files
